Professional
Added to YB: 2025-10-06
Pitch date: 2025-10-01
PHX.AX [neutral]
PharmX Technologies Limited
+6.06%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia.
Market Cap
AUD 77.8M
Pitch Price
AUD 0.13
Price Target
0.26 (+86%)
Dividend
N/A
EV/EBITDA
144.15
P/E
-294.78
EV/Sales
9.90
Sector
Software
Category
growth
Show full summary:
Infuse Partners Portfolio Holding: PharmX Technologies Limited
PHX.AX (holding update): Deep moat vs larger competitor FredIT who failed to compete. $1B non-drug products flow through systems - 5% take-rate = $50M high-margin revenue. Mgmt targets half that in 3-4yrs. Even with 50% multiple compression, stock could double. Risk: 10x sales, 10% growth, breakeven profits.
Read full article (2 min)